 | • レポートコード：QY2108PAL8836 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおける胃不全麻痺治療薬の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、胃不全麻痺治療薬の種類別市場規模（運動促進剤、制吐剤、その他）、用途別市場規模（糖尿病性胃不全麻痺、特発性胃不全麻痺）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界の胃不全麻痺治療薬市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界における胃不全麻痺治療薬の種類別市場規模（2016年-2027年）：運動促進剤、制吐剤、その他 ・世界における胃不全麻痺治療薬の用途別市場規模（2016年-2027年）：糖尿病性胃不全麻痺、特発性胃不全麻痺 ・胃不全麻痺治療薬の中国市場分析 - 胃不全麻痺治療薬の中国市場規模（2016年-2027年） - 中国における胃不全麻痺治療薬の主要プレイヤー別市場シェア - 中国における胃不全麻痺治療薬の種類別市場規模：運動促進剤、制吐剤、その他 - 中国における胃不全麻痺治療薬の用途別市場規模：糖尿病性胃不全麻痺、特発性胃不全麻痺 ・胃不全麻痺治療薬の北米市場（2016年-2027年） ・胃不全麻痺治療薬のヨーロッパ市場（2016年-2027年） ・胃不全麻痺治療薬のアジア太平洋市場（2016年-2027年） ・胃不全麻痺治療薬の中南米市場（2016年-2027年） ・胃不全麻痺治療薬の中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Sumitomo、Cadila Pharmaceuticals、Sanofi、Teva、Johnson & Johnson、Pfizer、Kyowa Kirin Pharmaceuticals、Hanmi Pharm、Ani Pharmaceuticals ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.
North America is the largest consumer of Gastroparesis Drugs in global market.The second place is Europe, following North America.
Market is not concentrated. Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva and Johnson & Johnsonare the leaders of the industry, and hold the key technologies and patent, with high-end customers.
Market Analysis and Insights: Global and China Gastroparesis Drugs Market
This report focuses on global and China Gastroparesis Drugs market.
In 2020, the global Gastroparesis Drugs market size was US$ 5438.2 million and it is expected to reach US$ 7285.3 million by the end of 2027, with a CAGR of 4.3% during 2021-2027. In China the Gastroparesis Drugs market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Gastroparesis Drugs Scope and Market Size
Gastroparesis Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Gastroparesis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Gastroparesis Drugs market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Prokinetic Agents
Antiemetic Agents
Others
Segment by Application
Diabetic Gastroparesis
Idiopathic Gastroparesis
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Sumitomo
Cadila Pharmaceuticals
Sanofi
Teva
Johnson & Johnson
Pfizer
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Ani Pharmaceuticals
1 Study Coverage
1.1 Gastroparesis Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Gastroparesis Drugs Market Size Growth Rate by Type
1.2.2 Prokinetic Agents
1.2.3 Antiemetic Agents
1.2.4 Others
1.3 Market by Application
1.3.1 Global Gastroparesis Drugs Market Size Growth Rate by Application
1.3.2 Diabetic Gastroparesis
1.3.3 Idiopathic Gastroparesis
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Gastroparesis Drugs Market Size, Estimates and Forecasts
2.1.1 Global Gastroparesis Drugs Revenue 2016-2027
2.1.2 Global Gastroparesis Drugs Sales 2016-2027
2.2 Global Gastroparesis Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Gastroparesis Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Gastroparesis Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Gastroparesis Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Gastroparesis Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Gastroparesis Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Gastroparesis Drugs Revenue Forecast by Region (2022-2027)
3 Global Gastroparesis Drugs Competitor Landscape by Players
3.1 Global Top Gastroparesis Drugs Manufacturers by Sales
3.1.1 Global Gastroparesis Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Gastroparesis Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Gastroparesis Drugs Manufacturers by Revenue
3.2.1 Key Gastroparesis Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Gastroparesis Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Gastroparesis Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Gastroparesis Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Gastroparesis Drugs Revenue in 2020
3.2.6 Global Gastroparesis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Gastroparesis Drugs Price by Manufacturers
3.4 Global Gastroparesis Drugs Manufacturing Base Distribution, Product Types
3.4.1 Gastroparesis Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gastroparesis Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Gastroparesis Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Gastroparesis Drugs Market Size by Type (2016-2021)
4.1.1 Global Gastroparesis Drugs Sales by Type (2016-2021)
4.1.2 Global Gastroparesis Drugs Revenue by Type (2016-2021)
4.1.3 Gastroparesis Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Gastroparesis Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Gastroparesis Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Gastroparesis Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Gastroparesis Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Gastroparesis Drugs Market Size by Application (2016-2021)
5.1.1 Global Gastroparesis Drugs Sales by Application (2016-2021)
5.1.2 Global Gastroparesis Drugs Revenue by Application (2016-2021)
5.1.3 Gastroparesis Drugs Price by Application (2016-2021)
5.2 Gastroparesis Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Gastroparesis Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Gastroparesis Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Gastroparesis Drugs Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Gastroparesis Drugs Market Size YoY Growth 2016-2027
6.1.1 China Gastroparesis Drugs Sales YoY Growth 2016-2027
6.1.2 China Gastroparesis Drugs Revenue YoY Growth 2016-2027
6.1.3 China Gastroparesis Drugs Market Share in Global Market 2016-2027
6.2 China Gastroparesis Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Gastroparesis Drugs Players by Sales (2016-2021)
6.2.2 China Top Gastroparesis Drugs Players by Revenue (2016-2021)
6.3 China Gastroparesis Drugs Historic Market Review by Type (2016-2021)
6.3.1 China Gastroparesis Drugs Sales Market Share by Type (2016-2021)
6.3.2 China Gastroparesis Drugs Revenue Market Share by Type (2016-2021)
6.3.3 China Gastroparesis Drugs Price by Type (2016-2021)
6.4 China Gastroparesis Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Gastroparesis Drugs Sales Forecast by Type (2022-2027)
6.4.2 China Gastroparesis Drugs Revenue Forecast by Type (2022-2027)
6.4.3 China Gastroparesis Drugs Price Forecast by Type (2022-2027)
6.5 China Gastroparesis Drugs Historic Market Review by Application (2016-2021)
6.5.1 China Gastroparesis Drugs Sales Market Share by Application (2016-2021)
6.5.2 China Gastroparesis Drugs Revenue Market Share by Application (2016-2021)
6.5.3 China Gastroparesis Drugs Price by Application (2016-2021)
6.6 China Gastroparesis Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Gastroparesis Drugs Sales Forecast by Application (2022-2027)
6.6.2 China Gastroparesis Drugs Revenue Forecast by Application (2022-2027)
6.6.3 China Gastroparesis Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Gastroparesis Drugs Market Size YoY Growth 2016-2027
7.2 North America Gastroparesis Drugs Market Facts & Figures by Country
7.2.1 North America Gastroparesis Drugs Sales by Country (2016-2021)
7.2.2 North America Gastroparesis Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Gastroparesis Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Gastroparesis Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Gastroparesis Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Gastroparesis Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Gastroparesis Drugs Market Size YoY Growth 2016-2027
9.2 Europe Gastroparesis Drugs Market Facts & Figures by Country
9.2.1 Europe Gastroparesis Drugs Sales by Country (2016-2021)
9.2.2 Europe Gastroparesis Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Gastroparesis Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Gastroparesis Drugs Market Facts & Figures by Country
10.2.1 Latin America Gastroparesis Drugs Sales by Country (2016-2021)
10.2.2 Latin America Gastroparesis Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Gastroparesis Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Gastroparesis Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Gastroparesis Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Gastroparesis Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Sumitomo
12.1.1 Sumitomo Corporation Information
12.1.2 Sumitomo Description and Business Overview
12.1.3 Sumitomo Gastroparesis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Sumitomo Gastroparesis Drugs Products Offered
12.1.5 Sumitomo Recent Development
12.2 Cadila Pharmaceuticals
12.2.1 Cadila Pharmaceuticals Corporation Information
12.2.2 Cadila Pharmaceuticals Description and Business Overview
12.2.3 Cadila Pharmaceuticals Gastroparesis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Cadila Pharmaceuticals Gastroparesis Drugs Products Offered
12.2.5 Cadila Pharmaceuticals Recent Development
12.3 Sanofi
12.3.1 Sanofi Corporation Information
12.3.2 Sanofi Description and Business Overview
12.3.3 Sanofi Gastroparesis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi Gastroparesis Drugs Products Offered
12.3.5 Sanofi Recent Development
12.4 Teva
12.4.1 Teva Corporation Information
12.4.2 Teva Description and Business Overview
12.4.3 Teva Gastroparesis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Teva Gastroparesis Drugs Products Offered
12.4.5 Teva Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Corporation Information
12.5.2 Johnson & Johnson Description and Business Overview
12.5.3 Johnson & Johnson Gastroparesis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Johnson & Johnson Gastroparesis Drugs Products Offered
12.5.5 Johnson & Johnson Recent Development
12.6 Pfizer
12.6.1 Pfizer Corporation Information
12.6.2 Pfizer Description and Business Overview
12.6.3 Pfizer Gastroparesis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Pfizer Gastroparesis Drugs Products Offered
12.6.5 Pfizer Recent Development
12.7 Kyowa Kirin Pharmaceuticals
12.7.1 Kyowa Kirin Pharmaceuticals Corporation Information
12.7.2 Kyowa Kirin Pharmaceuticals Description and Business Overview
12.7.3 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Products Offered
12.7.5 Kyowa Kirin Pharmaceuticals Recent Development
12.8 Hanmi Pharm
12.8.1 Hanmi Pharm Corporation Information
12.8.2 Hanmi Pharm Description and Business Overview
12.8.3 Hanmi Pharm Gastroparesis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Hanmi Pharm Gastroparesis Drugs Products Offered
12.8.5 Hanmi Pharm Recent Development
12.9 Ani Pharmaceuticals
12.9.1 Ani Pharmaceuticals Corporation Information
12.9.2 Ani Pharmaceuticals Description and Business Overview
12.9.3 Ani Pharmaceuticals Gastroparesis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Ani Pharmaceuticals Gastroparesis Drugs Products Offered
12.9.5 Ani Pharmaceuticals Recent Development
12.11 Sumitomo
12.11.1 Sumitomo Corporation Information
12.11.2 Sumitomo Description and Business Overview
12.11.3 Sumitomo Gastroparesis Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Sumitomo Gastroparesis Drugs Products Offered
12.11.5 Sumitomo Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Gastroparesis Drugs Industry Trends
13.2 Gastroparesis Drugs Market Drivers
13.3 Gastroparesis Drugs Market Challenges
13.4 Gastroparesis Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Gastroparesis Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Gastroparesis Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Prokinetic Agents
Table 3. Major Manufacturers of Antiemetic Agents
Table 4. Major Manufacturers of Others
Table 5. Global Gastroparesis Drugs Market Size Growth Rate by Application (2021-2027) & (Kg)
Table 6. Global Gastroparesis Drugs Market Size by Region (Kg) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Gastroparesis Drugs Sales by Regions (2016-2021) & (Kg)
Table 8. Global Gastroparesis Drugs Sales Market Share by Regions (2016-2021)
Table 9. Global Gastroparesis Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Gastroparesis Drugs Sales Forecast by Region (2022-2027) & (Kg)
Table 11. Global Gastroparesis Drugs Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Gastroparesis Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Gastroparesis Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Gastroparesis Drugs Sales by Manufacturers (2016-2021) (Kg)
Table 15. Global Gastroparesis Drugs Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Gastroparesis Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 17. Gastroparesis Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Gastroparesis Drugs Revenue Share by Manufacturers (2016-2021)
Table 19. Global Gastroparesis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Gastroparesis Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastroparesis Drugs as of 2020)
Table 21. Key Manufacturers Gastroparesis Drugs Price (2016-2021) (US$/mg)
Table 22. Gastroparesis Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Gastroparesis Drugs Product Type
Table 24. Date of International Manufacturers Enter into Gastroparesis Drugs Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Gastroparesis Drugs Sales by Type (2016-2021) (Kg)
Table 27. Global Gastroparesis Drugs Sales Share by Type (2016-2021)
Table 28. Global Gastroparesis Drugs Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Gastroparesis Drugs Revenue Share by Type (2016-2021)
Table 30. Gastroparesis Drugs Average Selling Price (ASP) by Type (2016-2021) & (US$/mg)
Table 31. Global Gastroparesis Drugs Sales Forecast by Type (2022-2027) & (Kg)
Table 32. Global Gastroparesis Drugs Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Gastroparesis Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Gastroparesis Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Gastroparesis Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/mg)
Table 36. Global Gastroparesis Drugs Sales by Application (2016-2021) (Kg)
Table 37. Global Gastroparesis Drugs Sales Share by Application (2016-2021)
Table 38. Global Gastroparesis Drugs Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Gastroparesis Drugs Revenue Share by Application (2016-2021)
Table 40. Gastroparesis Drugs Average Selling Price (ASP) by Application (2016-2021) & (US$/mg)
Table 41. Global Gastroparesis Drugs Sales Forecast by Application (2022-2027) & (Kg)
Table 42. Global Gastroparesis Drugs Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Gastroparesis Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Gastroparesis Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Gastroparesis Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/mg)
Table 46. China Gastroparesis Drugs Sales (Kg) of Key Companies (2016-2021)
Table 47. China Gastroparesis Drugs Sales Share by Company (2016-2021)
Table 48. China Gastroparesis Drugs Revenue (US$ Million) by Company (2016-2021)
Table 49. China Gastroparesis Drugs Revenue Share by Company (2016-2021)
Table 50. China Gastroparesis Drugs Sales (Kg) by Type (2016-2021)
Table 51. China Gastroparesis Drugs Sales Share by Type (2016-2021)
Table 52. China Gastroparesis Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Gastroparesis Drugs Price (US$/mg) by Type (2016-2021)
Table 54. China Gastroparesis Drugs Sales (Kg) by Type (2022-2027)
Table 55. China Gastroparesis Drugs Sales Share by Type (2022-2027)
Table 56. China Gastroparesis Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Gastroparesis Drugs Revenue Share by Type (2022-2027)
Table 58. China Gastroparesis Drugs Price (US$/mg) by Type (2022-2027)
Table 59. China Gastroparesis Drugs Sales (Kg) by Application (2016-2021)
Table 60. China Gastroparesis Drugs Sales Share by Application (2016-2021)
Table 61. China Gastroparesis Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China Gastroparesis Drugs Price (US$/mg) by Application (2016-2021)
Table 63. China Gastroparesis Drugs Sales (Kg) by Application (2022-2027)
Table 64. China Gastroparesis Drugs Sales Share by Application (2022-2027)
Table 65. China Gastroparesis Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China Gastroparesis Drugs Revenue Share by Application (2022-2027)
Table 67. China Gastroparesis Drugs Price (US$/mg) by Application (2022-2027)
Table 68. North America Gastroparesis Drugs Sales by Country (2016-2021) & (Kg)
Table 69. North America Gastroparesis Drugs Sales Market Share by Country (2016-2021)
Table 70. North America Gastroparesis Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Gastroparesis Drugs Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Gastroparesis Drugs Sales by Region (2016-2021) & (Kg)
Table 73. Asia Pacific Gastroparesis Drugs Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Gastroparesis Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Gastroparesis Drugs Revenue Market Share by Region (2016-2021)
Table 76. Europe Gastroparesis Drugs Sales by Country (2016-2021) & (Kg)
Table 77. Europe Gastroparesis Drugs Sales Market Share by Country (2016-2021)
Table 78. Europe Gastroparesis Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Gastroparesis Drugs Revenue Market Share by Country (2016-2021)
Table 80. Latin America Gastroparesis Drugs Sales by Country (2016-2021) & (Kg)
Table 81. Latin America Gastroparesis Drugs Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Gastroparesis Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Gastroparesis Drugs Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Gastroparesis Drugs Sales by Country (2016-2021) & (Kg)
Table 85. Middle East and Africa Gastroparesis Drugs Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Gastroparesis Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Gastroparesis Drugs Revenue Market Share by Country (2016-2021)
Table 88. Sumitomo Corporation Information
Table 89. Sumitomo Description and Business Overview
Table 90. Sumitomo Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2016-2021)
Table 91. Sumitomo Gastroparesis Drugs Product
Table 92. Sumitomo Recent Development
Table 93. Cadila Pharmaceuticals Corporation Information
Table 94. Cadila Pharmaceuticals Description and Business Overview
Table 95. Cadila Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2016-2021)
Table 96. Cadila Pharmaceuticals Product
Table 97. Cadila Pharmaceuticals Recent Development
Table 98. Sanofi Corporation Information
Table 99. Sanofi Description and Business Overview
Table 100. Sanofi Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2016-2021)
Table 101. Sanofi Product
Table 102. Sanofi Recent Development
Table 103. Teva Corporation Information
Table 104. Teva Description and Business Overview
Table 105. Teva Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2016-2021)
Table 106. Teva Product
Table 107. Teva Recent Development
Table 108. Johnson & Johnson Corporation Information
Table 109. Johnson & Johnson Description and Business Overview
Table 110. Johnson & Johnson Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2016-2021)
Table 111. Johnson & Johnson Product
Table 112. Johnson & Johnson Recent Development
Table 113. Pfizer Corporation Information
Table 114. Pfizer Description and Business Overview
Table 115. Pfizer Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2016-2021)
Table 116. Pfizer Product
Table 117. Pfizer Recent Development
Table 118. Kyowa Kirin Pharmaceuticals Corporation Information
Table 119. Kyowa Kirin Pharmaceuticals Description and Business Overview
Table 120. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2016-2021)
Table 121. Kyowa Kirin Pharmaceuticals Product
Table 122. Kyowa Kirin Pharmaceuticals Recent Development
Table 123. Hanmi Pharm Corporation Information
Table 124. Hanmi Pharm Description and Business Overview
Table 125. Hanmi Pharm Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2016-2021)
Table 126. Hanmi Pharm Product
Table 127. Hanmi Pharm Recent Development
Table 128. Ani Pharmaceuticals Corporation Information
Table 129. Ani Pharmaceuticals Description and Business Overview
Table 130. Ani Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2016-2021)
Table 131. Ani Pharmaceuticals Product
Table 132. Ani Pharmaceuticals Recent Development
Table 133. Gastroparesis Drugs Market Trends
Table 134. Gastroparesis Drugs Market Drivers
Table 135. Gastroparesis Drugs Market Challenges
Table 136. Gastroparesis Drugs Market Restraints
Table 137. Gastroparesis Drugs Customers List
Table 138. Gastroparesis Drugs Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Gastroparesis Drugs Product Picture
Figure 2. Global Gastroparesis Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Prokinetic Agents Product Picture
Figure 4. Antiemetic Agents Product Picture
Figure 5. Others Product Picture
Figure 6. Global Gastroparesis Drugs Sales Market Share by Application in 2020 & 2027
Figure 7. Diabetic Gastroparesis
Figure 8. Idiopathic Gastroparesis
Figure 9. Gastroparesis Drugs Report Years Considered
Figure 10. Global Gastroparesis Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Gastroparesis Drugs Market Size 2016-2027 (US$ Million)
Figure 12. Global Gastroparesis Drugs Sales 2016-2027 (Kg)
Figure 13. Global Gastroparesis Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Gastroparesis Drugs Sales Market Share by Region (2016-2021)
Figure 15. Global Gastroparesis Drugs Sales Market Share by Region in 2020
Figure 16. Global Gastroparesis Drugs Revenue Market Share by Region (2016-2021)
Figure 17. Global Gastroparesis Drugs Revenue Market Share by Region in 2020
Figure 18. Global Gastroparesis Drugs Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Gastroparesis Drugs Revenue in 2020
Figure 20. Gastroparesis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Gastroparesis Drugs Sales Market Share by Type (2016-2021)
Figure 22. Global Gastroparesis Drugs Sales Market Share by Type in 2020
Figure 23. Global Gastroparesis Drugs Revenue Market Share by Type (2016-2021)
Figure 24. Global Gastroparesis Drugs Revenue Market Share by Type in 2020
Figure 25. Global Gastroparesis Drugs Sales Market Share by Application (2016-2021)
Figure 26. Global Gastroparesis Drugs Sales Market Share by Application in 2020
Figure 27. Global Gastroparesis Drugs Revenue Market Share by Application (2016-2021)
Figure 28. Global Gastroparesis Drugs Revenue Market Share by Application in 2020
Figure 29. China Gastroparesis Drugs Sales Growth Rate 2016-2027 (Kg)
Figure 30. China Gastroparesis Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. China Gastroparesis Drugs Market Share in Global Market 2016-2027
Figure 32. China 5 and 10 Largest Gastroparesis Drugs Players Market Share by Revenue in Gastroparesis Drugs in 2020
Figure 33. China Gastroparesis Drugs Revenue Share by Type (2016-2021)
Figure 34. China Gastroparesis Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 35. China Gastroparesis Drugs Revenue Share by Application (2016-2021)
Figure 36. China Gastroparesis Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Gastroparesis Drugs Sales Growth Rate 2016-2021 (Kg)
Figure 38. North America Gastroparesis Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Gastroparesis Drugs Sales Market Share by Country in 2020
Figure 40. North America Gastroparesis Drugs Revenue Market Share by Country in 2020
Figure 41. U.S. Gastroparesis Drugs Sales Growth Rate (2016-2021) (Kg)
Figure 42. U.S. Gastroparesis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Gastroparesis Drugs Sales Growth Rate (2016-2021) (Kg)
Figure 44. Canada Gastroparesis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Gastroparesis Drugs Sales Growth Rate 2016-2021 (Kg)
Figure 46. Europe Gastroparesis Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Gastroparesis Drugs Sales Market Share by Country in 2020
Figure 48. Europe Gastroparesis Drugs Revenue Market Share by Country in 2020
Figure 49. Germany Gastroparesis Drugs Sales Growth Rate (2016-2021) (Kg)
Figure 50. Germany Gastroparesis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Gastroparesis Drugs Sales Growth Rate (2016-2021) (Kg)
Figure 52. France Gastroparesis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Gastroparesis Drugs Sales Growth Rate (2016-2021) (Kg)
Figure 54. U.K. Gastroparesis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Gastroparesis Drugs Sales Growth Rate (2016-2021) (Kg)
Figure 56. Italy Gastroparesis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Gastroparesis Drugs Sales Growth Rate (2016-2021) (Kg)
Figure 58. Russia Gastroparesis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Gastroparesis Drugs Sales Growth Rate 2016-2021 (Kg)
Figure 60. Asia Pacific Gastroparesis Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Gastroparesis Drugs Sales Market Share by Region in 2020
Figure 62. Asia Pacific Gastroparesis Drugs Revenue Market Share by Region in 2020
Figure 63. China Gastroparesis Drugs Sales Growth Rate (2016-2021) (Kg)
Figure 64. China Gastroparesis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Gastroparesis Drugs Sales Growth Rate (2016-2021) (Kg)
Figure 66. Japan Gastroparesis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Gastroparesis Drugs Sales Growth Rate (2016-2021) (Kg)
Figure 68. South Korea Gastroparesis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Gastroparesis Drugs Sales Growth Rate (2016-2021) (Kg)
Figure 70. India Gastroparesis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Gastroparesis Drugs Sales Growth Rate (2016-2021) (Kg)
Figure 72. Australia Gastroparesis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. China Taiwan Gastroparesis Drugs Sales Growth Rate (2016-2021) (Kg)
Figure 74. China Taiwan Gastroparesis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Gastroparesis Drugs Sales Growth Rate (2016-2021) (Kg)
Figure 76. Indonesia Gastroparesis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Gastroparesis Drugs Sales Growth Rate (2016-2021) (Kg)
Figure 78. Thailand Gastroparesis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Gastroparesis Drugs Sales Growth Rate (2016-2021) (Kg)
Figure 80. Malaysia Gastroparesis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Latin America Gastroparesis Drugs Sales Growth Rate 2016-2021 (Kg)
Figure 82. Latin America Gastroparesis Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 83. Latin America Gastroparesis Drugs Sales Market Share by Country in 2020
Figure 84. Latin America Gastroparesis Drugs Revenue Market Share by Country in 2020
Figure 85. Mexico Gastroparesis Drugs Sales Growth Rate (2016-2021) (Kg)
Figure 86. Mexico Gastroparesis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Brazil Gastroparesis Drugs Sales Growth Rate (2016-2021) (Kg)
Figure 88. Brazil Gastroparesis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Argentina Gastroparesis Drugs Sales Growth Rate (2016-2021) (Kg)
Figure 90. Argentina Gastroparesis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Middle East and Africa Gastroparesis Drugs Sales Growth Rate 2016-2021 (Kg)
Figure 92. Middle East and Africa Gastroparesis Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 93. Middle East and Africa Gastroparesis Drugs Sales Market Share by Country in 2020
Figure 94. Middle East and Africa Gastroparesis Drugs Revenue Market Share by Country in 2020
Figure 95. Turkey Gastroparesis Drugs Sales Growth Rate (2016-2021) (Kg)
Figure 96. Turkey Gastroparesis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Saudi Arabia Gastroparesis Drugs Sales Growth Rate (2016-2021) (Kg)
Figure 98. Saudi Arabia Gastroparesis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. UAE Gastroparesis Drugs Sales Growth Rate (2016-2021) (Kg)
Figure 100. UAE Gastroparesis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Gastroparesis Drugs Value Chain
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Bottom-up and Top-down Approaches for This Report
Figure 105. Data Triangulation
Figure 106. Key Executives Interviewed
鼻血治療薬の世界市場 2020年 Market Overview The global Epistaxis Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Epistaxis Drugs market report…- エクセナチド薬の世界市場 2020年 Market Overview The global Exenatide Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Exenatide Drugs market report…
- テデュグルチド薬の世界市場 2020年 Market Overview The global Teduglutide Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Teduglutide Drugs market re…
- ニボルマブ薬の世界市場 2020年 Market Overview The Nivolumab Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- リラグルチド薬の世界市場 2020年 Market Overview The global Liraglutide Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Liraglutide Drugs market re…